[Risk/benefit profile of hormone replacement therapy in postmenopause. From research to practice]
Related Experiment Video
Updated: Oct 30, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
1Laboratorio di Farmacologia Clinica, Istituto di Ricerche Farmacologiche Mario Negri, Milano.
Abstract:
The menopause has been transformed from a marginal subject to a central event of medical interest. The gap between evidence derived from epidemiological research and clinical practice seems to be wider in post-menopausal area than in other fields. Most of the evidence were obtained from observational epidemiological studies and only in part from randomized clinical trials. Current results suggest that hormonal replacement therapy may represent a useful treatment and probably a preventive tool. Nevertheless, given the side effects and the risks involved, greater attention should be given to the individual choices of the women.
Related Concept Videos
Menopause
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio
For example, in a clinical trial evaluating a...
Hormonal Regulation
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Drug Toxicity: Risk factors